Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT001 in Friedreich's Ataxia
NCT04102501Phase 3Completed
- Sponsor
- BioJiva LLC
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of RT001 in Friedreich's ataxia (FA), sponsored by BioJiva LLC. Started Oct 2019; status: completed.
02
Drugs
RT001
03
Conditions
Friedreich's ataxia (FA)
Beyond the preview
Go deeper on NCT04102501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04102501.